[
    [
        {
            "time": "",
            "original_text": "上海莱士：孙公司拟接受BioTest的授权在中国销售人血白蛋白注射液",
            "features": {
                "keywords": [
                    "上海莱士",
                    "BioTest",
                    "人血白蛋白注射液",
                    "授权",
                    "销售"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上海莱士：孙公司拟接受BioTest的授权在中国销售人血白蛋白注射液",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "上海莱士2019前三季营收净利大增 逐步退出投资业务",
            "features": {
                "keywords": [
                    "上海莱士",
                    "2019",
                    "前三季",
                    "营收",
                    "净利",
                    "大增",
                    "投资业务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海莱士2019前三季营收净利大增 逐步退出投资业务",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "上海莱士第三季度营收上涨38.01%，多家大股东股权质押比超90%",
            "features": {
                "keywords": [
                    "上海莱士",
                    "第三季度",
                    "营收",
                    "上涨",
                    "股权质押",
                    "90%"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海莱士第三季度营收上涨38.01%，多家大股东股权质押比超90%",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "上海莱士公布三季报 前三季净利盈利6.0595亿",
            "features": {
                "keywords": [
                    "上海莱士",
                    "三季报",
                    "前三季",
                    "净利",
                    "盈利"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海莱士公布三季报 前三季净利盈利6.0595亿",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "上海莱士(002252.SZ)孙公司拟接受BioTest的授权在中国地区销售人血白蛋白注射液",
            "features": {
                "keywords": [
                    "上海莱士",
                    "BioTest",
                    "人血白蛋白注射液",
                    "授权",
                    "销售"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上海莱士(002252.SZ)孙公司拟接受BioTest的授权在中国地区销售人血白蛋白注射液",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "上海莱士(002252.SZ)：第三季度扣非净利1.97亿元 同比增93.80%",
            "features": {
                "keywords": [
                    "上海莱士",
                    "第三季度",
                    "扣非净利",
                    "同比增",
                    "93.80%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海莱士(002252.SZ)：第三季度扣非净利1.97亿元 同比增93.80%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]